Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 23, 2026
Why Is CF Industries Holdings (CF) Stock Down -6% Today?

Why Is CF Industries Holdings (CF) Stock Down -6% Today?

Key Takeaways

  • CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41
  • Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks
  • Secondary drivers: Broader risk-off sentiment across commodity markets; Mizuho's March 18 downgrade to Underperform (price target: $100) continues to weigh on sentiment
  • Sector context: CF had surged over 34% year-to-date through mid-March, fueled almost entirely by the Iran war-driven closure of the Strait of Hormuz — a reversal in that narrative directly pressures valuations
  • What traders are watching: Whether Iran complies with the Strait of Hormuz reopening ultimatum, natural gas price direction, and whether the fertilizer price premium begins to unwind across the futures market

Opening Summary

CF Industries Holdings, Inc. (CF) is one of the world's largest manufacturers of nitrogen-based fertilizers and hydrogen products, operating a network of production facilities primarily in North America. The Northbrook, Illinois-based company is a benchmark name in the agricultural inputs sector and is particularly sensitive to natural gas prices and global nitrogen supply dynamics.

In Monday's premarket session, CF shares fell approximately 6%, trading near $117.41 after closing Friday's session at $124.90. The decline marks a sharp reversal from a multi-week geopolitically driven rally and is directly tied to weekend developments suggesting a potential de-escalation of the Iran conflict — the very catalyst that had propelled the stock to a 52-week high of $137.44.

Geopolitical De-escalation Removes the Core Bull Thesis

The most direct driver of Monday's sell-off is a weekend announcement by President Trump that the United States would pause strikes on Iranian power plants and energy infrastructure for five days following what he described as "very good" diplomatic signals from Tehran. For fertilizer traders and equity investors, this statement carries significant weight: the entire 2026 rally in CF shares was built on the assumption that the Strait of Hormuz — a chokepoint through which an estimated one-fifth of global oil and gas and over 30% of the world's fertilizer supply transits — would remain disrupted for an extended period.

If diplomatic progress accelerates and the Strait reopens, the scarcity premium embedded in nitrogen fertilizer prices — and by extension CF's earnings outlook — begins to fade. Urea prices at New Orleans had surged from below $500 per ton before February 27 to over $650 per ton by mid-March, a spike that directly lifted CF's projected margins. Any reversal of that dynamic would compress the earnings uplift analysts had begun pricing in.

Mizuho Downgrade Continues to Pressure Sentiment

Compounding Monday's premarket weakness is the lingering impact of a March 18 downgrade from Mizuho Securities, which cut CF to Underperform from Neutral with a price target of $100 — implying roughly 20% downside from where the stock traded at the time. Analyst Edlain Rodriguez argued that the stock's 24% gain since early March had "overdone" the geopolitical supply disruption trade, and that the bulk of the earnings uplift from elevated fertilizer prices had likely already been captured.

While other analysts remain more constructive — BMO Capital Markets raised its target to $140 and maintained an Outperform rating in mid-March  — the Mizuho call introduced a credible bear case that has resonated with traders as geopolitical risk premiums begin to compress.

Market Context and Trading Activity

The broader risk backdrop on Monday morning is mixed. Asian equity markets sold off on March 23 as investors processed the escalating geopolitical situation and gold retreated sharply, erasing much of its 2026 gains. Commodity-linked equities are trading with notable volatility as traders reassess whether the Iran conflict will remain a lasting supply disruption or a transient shock.

CF's peer group is also under pressure. Mosaic (MOS) and Nutrien (NTR) have both experienced recent pullbacks as the fertilizer supply-disruption trade faces scrutiny. From a technical standpoint, CF had already retreated from its peak of approximately $136 on March 12–13 and was trending lower into Friday's close at $124.90 — a pattern of lower highs that suggests institutional profit-taking has been underway for over a week. A break below the $117–$118 zone in premarket trading tests the stock's near-term support structure and could invite further algorithmic selling.

Trending AI Robots

For traders looking to navigate volatile sessions like today's in CF or across the broader fertilizer and commodities sector, Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers. Only the highest-performing bots under current market conditions are featured in the curated Trending AI Robots section, making it easier to identify strategies that are working right now. These bots vary by trading style, timeframe, risk parameters, and performance metrics — spanning momentum, mean-reversion, breakout, and swing strategies. Whether you're looking to manage exposure during geopolitical uncertainty or capture opportunities as sector dynamics shift, exploring the Trending AI Robots page is a professional starting point.

What Comes Next for CF

The most critical near-term variable for CF is the trajectory of the Iran conflict and the status of the Strait of Hormuz. The company's annual general meeting is scheduled for April 28, 2026, and investors will be closely watching for any updated management commentary on nitrogen pricing trends heading into the spring planting season. With the stock trading near $117–$118 in premarket — down more than 14% from its March highs — analysts holding bullish targets (BMO at $140, Barclays at $120) will face pressure to reassess assumptions if the geopolitical premium fully unwinds.

Key risks include a rapid normalization of urea and ammonia prices if Strait of Hormuz shipping lanes reopen, ongoing natural gas price volatility affecting production economics, and the potential for further analyst downgrades should the fertilizer price spike prove short-lived. On the upside, if diplomatic efforts fail and the conflict re-escalates, the supply disruption thesis returns and the stock could recover quickly.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: CF

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Aroon Indicator for CF shows an upward move is likely

CF's Aroon Indicator triggered a bullish signal on August 03, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 276 similar instances where the Aroon Indicator showed a similar pattern. In of the 276 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 17, 2026. You may want to consider a long position or call options on CF as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CF just turned positive on August 20, 2026. Looking at past instances where CF's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

CF moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CF advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CF moved out of overbought territory on July 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CF broke above its upper Bollinger Band on August 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CF's P/B Ratio (3.412) is slightly higher than the industry average of (1.518). P/E Ratio (9.614) is within average values for comparable stocks, (44.382). CF's Projected Growth (PEG Ratio) (0.435) is slightly lower than the industry average of (1.249). Dividend Yield (0.016) settles around the average of (0.040) among similar stocks. P/S Ratio (2.618) is also within normal values, averaging (1.482).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 10.16B. The market cap for tickers in the group ranges from 14.68K to 54.57B. CTVA holds the highest valuation in this group at 54.57B. The lowest valued company is CGSI at 14.68K.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was 4%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -8%. MOS experienced the highest price growth at 13%, while NXTS experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 99%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was 43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 58
Price Growth Rating: 54
SMR Rating: 81
Profit Risk Rating: 79
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
CF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of nitrogen fertilizer products

Industry ChemicalsAgricultural

Profile
Details
Industry
Chemicals Agricultural
Address
2375 Waterview Drive
Phone
+1 847 405-2400
Employees
2700
Web
https://www.cfindustries.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.